Literature DB >> 29312759

Virtual fluoroscopy during transbronchial biopsy for locating ground-glass nodules not visible on X-ray fluoroscopy.

Toshiyuki Nakai1, Takehiro Izumo2, Yuji Matsumoto1, Takaaki Tsuchida1.   

Abstract

BACKGROUND: Virtual fluoroscopy (VF) is a novel guided technique that provides ray summation images of target lesions similar to X-ray fluoroscopy. Endobronchial ultrasound with a guide sheath (EBUS-GS) is a useful modality for imaging ground-glass nodules (GGNs) but is not ideal for GGNs that cannot be detected on X-ray fluoroscopy. We evaluated whether the addition of VF to EBUS-GS improved the diagnostic yield.
METHODS: Consecutive patients who had undergone diagnostic bronchoscopy for GGNs that were not detected on X-ray fluoroscopy between September 2012 and January 2016 were retrospectively enrolled. The patients were divided into two groups: a non-VF group [performed using conventional thin-section computed tomography (CT), X-ray fluoroscopy, EBUS-GS, and virtual bronchoscopy for reference], and a VF group (performed using additional VF to non-VF group). We then compared the diagnostic yields between the two groups and performed a multivariate analysis to identify factors associated with an increased diagnostic yield.
RESULTS: A total of 74 patients (VF, 35 patients; non-VF, 39 patients) were enrolled and were included in the analysis. The diagnostic yield was significantly higher in the VF group (77.1%) than in the non-VF group (51.2%, P=0.030). There were no clinically significant complications in either group. In the multivariate analysis, a positive bronchus sign [odds ratio (ORs), 5.41; 95% confidence interval (CI), 1.36-21.40] and the use of VF (odds ratio, 3.68; 95% confidence interval, 1.16-11.60) were significantly associated with successful bronchoscopic diagnosis.
CONCLUSIONS: The addition of VF to EBUS-GS helped to identify GGNs that were not visible on X-ray fluoroscopy.

Entities:  

Keywords:  Lung cancer; bronchoscopy; ground-glass nodule (GGN); radial endobronchial ultrasound with a guide sheath (EBUS-GS); virtual bronchoscopy (VB); virtual fluoroscopy (VF)

Year:  2017        PMID: 29312759      PMCID: PMC5756945          DOI: 10.21037/jtd.2017.10.01

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  30 in total

1.  CT fluoroscopy-guided cutting needle biopsy of focal pure ground-glass opacity lung lesions: diagnostic yield in 83 lesions.

Authors:  Daisaku Inoue; Hideo Gobara; Takao Hiraki; Hidefumi Mimura; Katsuya Kato; Kentaro Shibamoto; Tatsuhiko Iishi; Yusuke Matsui; Shinichi Toyooka; Susumu Kanazawa
Journal:  Eur J Radiol       Date:  2010-12-28       Impact factor: 3.528

2.  Malignant versus benign nodules at CT screening for lung cancer: comparison of thin-section CT findings.

Authors:  Feng Li; Shusuke Sone; Hiroyuki Abe; Heber Macmahon; Kunio Doi
Journal:  Radiology       Date:  2004-10-21       Impact factor: 11.105

3.  Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society.

Authors:  Heber MacMahon; John H M Austin; Gordon Gamsu; Christian J Herold; James R Jett; David P Naidich; Edward F Patz; Stephen J Swensen
Journal:  Radiology       Date:  2005-11       Impact factor: 11.105

4.  Bronchoscopy for Pulmonary Peripheral Lesions With Virtual Fluoroscopic Preprocedural Planning Combined With EBUS-GS: A Pilot Study.

Authors:  Munehisa Fukusumi; Yoshiaki Ichinose; Yoshihito Arimoto; Shinjiro Takeoka; Chie Homma; Hiroyasu Matsuoka; Atsuto Mouri; Yoichiro Hamamoto; Junichi Matsumoto; Mitsuhiro Kamimura
Journal:  J Bronchology Interv Pulmonol       Date:  2016-04

5.  The diagnostic utility of endobronchial ultrasonography with a guide sheath and tomosynthesis images for ground glass opacity pulmonary lesions.

Authors:  Takehiro Izumo; Shinji Sasada; Christine Chavez; Takaaki Tsuchida
Journal:  J Thorac Dis       Date:  2013-12       Impact factor: 2.895

6.  Solitary pulmonary nodules. CT-bronchoscopic correlation.

Authors:  D P Naidich; R Sussman; W L Kutcher; C P Aranda; S M Garay; N A Ettenger
Journal:  Chest       Date:  1988-03       Impact factor: 9.410

Review 7.  Ground-glass opacity nodules: histopathology, imaging evaluation, and clinical implications.

Authors:  Ho Yun Lee; Kyung Soo Lee
Journal:  J Thorac Imaging       Date:  2011-05       Impact factor: 3.000

8.  Factors related to diagnostic yield of transbronchial biopsy using endobronchial ultrasonography with a guide sheath in small peripheral pulmonary lesions.

Authors:  Noriyuki Yamada; Koichi Yamazaki; Noriaki Kurimoto; Hajime Asahina; Eiki Kikuchi; Naofumi Shinagawa; Satoshi Oizumi; Masaharu Nishimura
Journal:  Chest       Date:  2007-06-15       Impact factor: 9.410

9.  CT-guided needle biopsy of lung lesions: a survey of severe complication based on 9783 biopsies in Japan.

Authors:  Noriyuki Tomiyama; Yoshifumi Yasuhara; Yasuo Nakajima; Shuji Adachi; Yasuaki Arai; Masahiko Kusumoto; Kenji Eguchi; Keiko Kuriyama; Fumikazu Sakai; Masayuki Noguchi; Kiyoshi Murata; Sadayuki Murayama; Teruhito Mochizuki; Kiyoshi Mori; Kozo Yamada
Journal:  Eur J Radiol       Date:  2006-03-10       Impact factor: 3.528

10.  Blizzard Sign as a specific endobronchial ultrasound image for ground glass opacity: A case report.

Authors:  Shinji Sasada; Takehiro Izumo; Christine Chavez; Takaaki Tsuchida
Journal:  Respir Med Case Rep       Date:  2014-03-15
View more
  2 in total

1.  Diagnostic value of a new cryoprobe for peripheral pulmonary lesions: a prospective study.

Authors:  Midori Tanaka; Yuji Matsumoto; Tatsuya Imabayashi; Takuya Kawahara; Takaaki Tsuchida
Journal:  BMC Pulm Med       Date:  2022-06-10       Impact factor: 3.320

2.  Safety profile and risk factors for bleeding in transbronchial cryobiopsy using a two-scope technique for peripheral pulmonary lesions.

Authors:  Toshiyuki Nakai; Tetsuya Watanabe; Yuto Kaimi; Koichi Ogawa; Yoshiya Matsumoto; Kenji Sawa; Atsuko Okamoto; Kanako Sato; Kazuhisa Asai; Yuji Matsumoto; Masahiko Ohsawa; Tomoya Kawaguchi
Journal:  BMC Pulm Med       Date:  2022-01-10       Impact factor: 3.317

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.